Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations
Impact of Obesity and Weight-Loss Interventions on Immune-Surveillance Mechanisms
Segmental Aneusomy Between Blocks of Duplicated DNA
Adult AIDS Clinical Trials Unit
Regulating Extracellular Matrix - Diabetic Kidney Disease
Recently added grants:
Post-Initiation control of transcription in inflammatory macrophages
The variable disease potential of group A Streptococcus isolates: a link to puerperal infections
T Cell Recognition of Disulfide Modified Antigens
Inititation and elongation of HDV RNAs
Apply an imaging flow cytometry method to screen chemical libraries for identifying and repurposing novel drugs against coccidioidomycosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07155-16-0-1
Application #
7574917
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ St. Jude Children's Research Hospital
$456,619
NIH 2007
N01 HL
Pedriatric Hydroxyurea Phase III Clinical Trial Clinical
Wang, Winfred C. /
$496,007
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant